The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Full text access
¿En pacientes con enfermedad renal crónica estadios 3-4 con anemia, ¿es preferible la normalización de la hemoglobina a la corrección parcial de la anemia para la disminución de los eventos cardiovasculares?
Is it better to normalize hemoglobin rather than partially correcting anemia in stages 3-4 chronic renal disease patients to decrease cardiovascular events?
Visits
6910
R. Saracho Rotaeche
This item has received
Article information
Full text is only available in PDF




